Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Neoplasms 3 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Gynecological Cancer 1 Genital Diseases, Female 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1

Interventions

Oxaliplatin 5 Mitomycin 4 Hyperthermic Intraperitoneal Chemotherapy 4 Fluorouracil 4 Cisplatin 4 Paclitaxel 3 Doxorubicin 3 Standard of Care 2 Leucovorin 2 Docetaxel 2 Blood Specimen Collection 2 Bevacizumab 2 sodium thiosulfate 1 relacorilant 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 dehydroftorafur 1 X-Rays 1 Topotecan 1 Specimen Handling 1 Practice Guidelines as Topic 1 Platinum 1 Pancreatectomy 1 Pafolacianine 1 Observation 1 Mitozytrex 1 Magnetic Resonance Spectroscopy 1 Letrozole 1 Laparoscopy 1 LY-2157299 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Peritoneal Neoplasms × Laparoscopy × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡